IDegAsp 50 (insulin degludec/insulin aspart)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IDegAsp 50 (insulin degludec/insulin aspart), covering 2016-01-15 to 2016-01-15. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Characteristics of Explorative Formulations of Insulin Degludec and IDegAsp 50 in Healthy Japanese Subjects [Phase 1]